BioMedPartners
BioMedInvest AG I
Portfolio BioMedInvest AG I
Board of Directors
News
Investors Access
BioMedInvest AG II
Portfolio BioMedInvest AG II
Board of Directors
News
BioMedCredit AG
Portfolio
Board of Directors
News
Investors Access
Team
Investment Team
Venture Partners
Advisors
Office
Ethical Values
Contact
How to find us
Imprint and Disclaimer
Sitemap
Sitemap
Overview Website
BioMedPartners
BioMedInvest AG I
Portfolio BioMedInvest AG I
Private Companies
4-Antibody AG
7TM Pharma A/S
Affimed Therapeutics AG
Dolthera GmbH
Eyesense AG
Okairos AG
Oncalis AG
Polyphor AG
Spinelab AG
Symetis AG
Vivendy Therapeutics AG
SuppreMol GmbH
Lumavita AG
Delenex Therapeutics AG
IPOs / M&A
Arpida AG
Glycart Biotechnology AG
Santhera Pharmaceuticals AG
Thommen Medical AG
ESBATech AG
Board of Directors
10Pfeifer, Prof. Dr. Andrea
Meier, Dr. Jürg
Geilinger, Dr. Ulrich
Hentsch, Bénédict G. F.
Vischer, Dr. Ulrich
Prof. Dr. Erich Wintermantel
News
Recent Events
Recent Events
Recent Events
Recent Events
Recent Events
Recent Events
Recent Events
Recent Events
Recent Events
Arpida IPO
SpineLab Erste Finanzierung
SpineLab First Financing
Neue Seite
Neue Seite
Vivendy Therapeutics AG Series A Financing Round
Neue Seite
Neue Seite
SuppreMol GmbH
Polyphor Ltd
Polyphor Ltd
Lumavita AG
Polyphor Ltd
BioMed Team
SuppreMol GmbH
SuppreMol engl
Spinelab AG
ESBATech Press Release
SuppreMol PR_E
SuppreMol PR_D
SuppreMol 19.04.2010
SuppreMol 19th April 2010
Okairòs AG - Series B Financing
SuppreMol 20101201 DE
SuppreMol GmbH 20101201_E
20110124 SuppreMol PR E
20110124 SuppreMol PR D
Okairos PR 20110913
Symetis PR 20111002
Investors Access
BioMedInvest AG II
Portfolio BioMedInvest AG II
Activaero GmbH
Evolva SA
Curetis AG
Vaximm AG
Sequana Medical AG
Anergis SA
Aleva Neurotherapeutics SA
Board of Directors
News
Press Release BioMedInvest II LP, first closing
Evolva SA Press Release
Activaero GmbH
Curetis AG
Press Release BioMedInvest II LP, second closing
Press Release BioMedInvest II LP, finales Closing (D)
Press Release Evolva, 13th December 2010
Evolva SA PR 20101216
NovaShunt AG 20110309
PR Anergis SA 20110328
20110713 Sequana Medical
Aleva Neurotherapeutics SA
BioMedCredit AG
Portfolio
Develco Pharma AG
Lipomed AG
Xiril AG
idiag AG
Degradable Solutions AG
Geneva Bioinformatics (GeneBio) SA
Board of Directors
Afting, Prof. Dr. Dr. Ernst-Günter
10Hufschmid, Hans-Rudolf
Meier, Dr. Henri B.
Wehrli, Dr. Rudolf
News
First Closing of BioMedCredit AG
Investment in Lipomed AG
Investment in Xiril AG
Investment in Allevia AG
Investment in Develco Pharma AG
Investment in idiag AG
Wachstumsfinanzierung der idiag AG
Investment in KLIMAmed AG
Investment in Degradable Solutions AG
Wachstumsfinanzierung der Degradable Solutions AG
Verstärkung BioMedPartners Team durch Josef Bissig
Press Release DS 20111109
Investors Access
Team
Investment Team
20Ries, Dr. Gerhard
30Hosang, Dr. Markus
40Möller, Thomas
Fäs, Stefan
Dr. Richard Munton
Venture Partners
60Burgermeister, Patrick
Fenner, Prof. Dr. Helmut
Dr. Karl Deres
Bissig Josef
Advisors
Burger, Prof. Dr. Max
Kalden, Prof. Dr. med. Dr. h.c. Joachim R.
Michel, Toni
Meyer, Prof. Dr. med. Urs A
Locher, Erwin
Office
Lauscher, Fiona, Office Manager
Ethical Values
Contact
How to find us
Imprint and Disclaimer
© BioMedPartners 2007